Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard Baidoo

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
The American Journal of Gastroenterology|March 9, 2016
Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal StudyToufic A Kabbani, Ioannis E Koutroubakis, Robert E Schoen, et al.
Inflammatory Bowel Diseases|February 26, 2011
Clinical course of Crohn's disease following treatment of lymphomaMarwa El Mourabet, Jana G Hashash, Nicholas H Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 23, 2013
Association between telephone activity and features of patients with inflammatory bowel diseaseClaudia Ramos-Rivers, Miguel Regueiro, Eric J Vargas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 6, 2018
Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit AllGil Y Melmed, Gilaad G Kaplan, Miles P Sparrow, et al.
Inflammatory Bowel Diseases|April 21, 2017
IBD LIVE Series-Case 7: The Brain-Gut Connection and the Importance of Integrated Care in IBDBenjamin H Click, Julia B Greer, Miguel D Regueiro, et al.
Inflammatory Bowel Diseases|July 22, 2015
Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent HospitalizationBenjamin Click, Eric J Vargas, Alyce M Anderson, et al.
The American Journal of Gastroenterology|July 15, 2024
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel DiseaseHannah K Systrom, Victoria Rai, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2015
Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled TrialsJennifer L Jones, Gilaad G Kaplan, Laurent Peyrin-Biroulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 11, 2010
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit allGil Y Melmed, Brennan M Spiegel, Brian Bressler, et al.
Inflammatory Bowel Diseases|October 19, 2016
IBD LIVE Case Series-Case 6Dhyan Rajan, Julia B Greer, Miguel D Regueiro, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The American Journal of Gastroenterology|March 9, 2016
Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal StudyToufic A Kabbani, Ioannis E Koutroubakis, Robert E Schoen, et al.
Inflammatory Bowel Diseases|February 26, 2011
Clinical course of Crohn's disease following treatment of lymphomaMarwa El Mourabet, Jana G Hashash, Nicholas H Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 23, 2013
Association between telephone activity and features of patients with inflammatory bowel diseaseClaudia Ramos-Rivers, Miguel Regueiro, Eric J Vargas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 6, 2018
Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit AllGil Y Melmed, Gilaad G Kaplan, Miles P Sparrow, et al.
Inflammatory Bowel Diseases|April 21, 2017
IBD LIVE Series-Case 7: The Brain-Gut Connection and the Importance of Integrated Care in IBDBenjamin H Click, Julia B Greer, Miguel D Regueiro, et al.
Inflammatory Bowel Diseases|July 22, 2015
Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent HospitalizationBenjamin Click, Eric J Vargas, Alyce M Anderson, et al.
The American Journal of Gastroenterology|July 15, 2024
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel DiseaseHannah K Systrom, Victoria Rai, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2015
Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled TrialsJennifer L Jones, Gilaad G Kaplan, Laurent Peyrin-Biroulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 11, 2010
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit allGil Y Melmed, Brennan M Spiegel, Brian Bressler, et al.
Inflammatory Bowel Diseases|October 19, 2016
IBD LIVE Case Series-Case 6Dhyan Rajan, Julia B Greer, Miguel D Regueiro, et al.
Pageof 5